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Quantiﬁcation of gold nanoparticle 
cell uptake under controlled biological 
conditions and adequate resolution
Aim: We examined cellular uptake mechanisms of ﬂuorescently labeled polymer-coated 
gold nanoparticles (NPs) under different biological conditions by two quantitative, 
microscopic approaches. Materials & methods: Uptake mechanisms were evaluated 
using endocytotic inhibitors that were tested for speciﬁcity and cytotoxicity. Cellular 
uptake of gold NPs was analyzed either by laser scanning microscopy or transmission 
electron microscopy, and quantiﬁed by means of stereology using cells from the 
same experiment. Results: Optimal inhibitor conditions were only achieved with 
chlorpromazine (clathrin-mediated endocytosis) and methyl-E-cyclodextrin (caveolin-
mediated endocytosis). A signiﬁcant methyl-E-cyclodextrin-mediated inhibition 
(63–69%) and chlorpromazine-mediated increase (43–98%) of intracellular NPs was 
demonstrated with both imaging techniques, suggesting a predominant uptake via 
caveolin-medicated endocytois. Transmission electron microscopy imaging revealed 
more than 95% of NPs localized in intracellular vesicles and approximately 150-times 
more NP events/cell were detected than by laser scanning microscopy. Conclusion: 
We emphasize the importance of studying NP–cell interactions under controlled 
experimental conditions and at adequate microscopic resolution in combination with 
stereology.
Keywords: ELECTRON MICROSCOPY s ENDOCYTOSIS INHIBITION s LASER SCANNING MICROSCOPY 
s NANOPARTICLE UPTAKE s POLYMERCOATED GOLD NANOPARTICLE s STEREOLOGY
In recent years, various types of nanoparticles 
(NPs; <100 nm in all three dimensions, ISO 
TS 27687:2008) have been designed for 
potential biomedical and pharmaceutical 
applications, such as vehicles for targeted drug 
delivery, nucleic acids, biomedical imaging 
or biosensing [1–3]. Therefore, an increasing 
number of research studies have focused on 
the interaction of NPs with biocellular systems 
[4,5]. To analyze different types of NP–cell 
interactions, such as cellular NP uptake, 
it is essential to have valuable techniques 
for visualization and quantiﬁcation, which 
are mainly based on spectroscopy or 
microscopy [6].
The method of choice for the intracellular 
detection of NPs depends on the charac-
teristics of the particles (ﬂuorescence, size, 
and structure or electron density) and on 
the cellular structure of interest. Advantages 
of spectroscopy and different microscopic 
techniques have been reviewed in detail 
elsewhere [6,7]. In brief, spectroscopy such as 
inductively coupled plasma-mass spectroscopy 
[8] allows the quantiﬁcation and detection of 
chemical NP elements within the cell, but 
does not provide any further information on 
the NP location within the cell. Fluorescence 
or laser scanning microscopy (LSM) allows 
real-time analysis or co-localization studies 
with ﬂuorescently labeled structures [9]. Trans-
mission electron microscopy (TEM) provides 
the highest resolution and allows quanti-
ﬁcation of NPs in sub cellular structures [10]. 
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However, sample preparation and NP quantiﬁcation 
might be more labor intensive for TEM analysis and 
no real-time imaging can be performed. For this 
reason, many uptake studies use LSM to analyze 
the intracellular NP uptake and distribution [11,12]. 
Nevertheless, conventional LSM is limited in its spatial 
resolution by the optical diffraction limit and individual 
NPs cannot be resolved and quantiﬁed as single NPs if 
their mean distance is less than 200 nm.
In the current study we aimed to analyze cellular 
NP uptake by LSM and TEM. We therefore used 
gold (Au) NPs with a mean inorganic core diameter 
of 13 nm, coated with a polymer shell (isobutylene alt-
maleic anhydride with 75% dodecylamine) and the 
red ﬂuorescence marker ATTO 590 [9]. These NPs 
can easily be detected by TEM because of gold’s high 
electron density and by LSM due to their ﬂuorescent 
label. Furthermore, Au NPs have recently attracted a 
lot of interest concerning biological applications [13]. Au 
NPs are readily incorporated by many different types of 
cells and were found to be suitable in nanomedicine [13] 
since they show low toxicity [14,15], have convenient 
characteristics, like the potential to be coated with target 
molecules [16], and can be used in biomedical imaging 
[3]. Different in vitro and in vivo studies made use of 
similar sized Au NPs, which were coated with medical 
substrates such as drugs or DNA [17–19].
Additionally, we investigated the uptake mechanisms 
for Au NPs into human alveolar epithelial cells (A549). 
Cellular NP uptake mechanisms have already been the 
subject of many investigations, and there is convincing 
evidence that different endocytotic mechanisms are 
involved, such as phagocytosis, macropino cytosis, 
clathrin-mediated endocytosis, caveolae-mediated 
endo cytosis, clathrin- and caveolin-independent endo-
cytosis, and direct entering mechanisms summarized 
as adhesive interactions (reviewed in [20–22]). The 
different endocytotic pathways might be characteristic 
for speciﬁc cell types and further determine intracellular 
NP trafﬁcking and fate [23]. It has been further shown 
that NP coatings induce speciﬁc endocytotic uptake 
mechanisms, either directly or via protein coating 
through interaction with their microenvironment [24,25].
To analyze the endocytotic uptake mechanism of Au 
NPs, speciﬁc inhibition of different pathways has been 
performed. Chlorpromazine hydrochloride is commonly 
used as an inhibitor of clathrin- mediated endocyto-
sis, by leading to a loss of clathrin and the AP2 adap-
tor complex from the surface of the cell [26]. Further-
more, treatment of A549 cells with chlorpromazine was 
shown to speciﬁcally inhibit the uptake of the serum 
protein transferrin, which is known to enter the cells via 
clathrin-mediated endo cytosis [27]. Fluorescently labeled 
transferrin was therefore used as a positive control to 
test for inhibitors of clathrin-mediated endo cytosis. 
Caveolae and lipid raft internalization was shown to be 
inhibited by nystatin, ﬁlipin and methyl-E-cyclodextrin 
(mEcd) via alteration of the structure and function of 
the membrane [26]. Filipin and nystatin were described 
to be very speciﬁc without inﬂuencing clathrin-mediated 
endocytosis and macropino cytosis (reviewed in [26]). 
They have been tested in combination with choleratoxin 
subunit b (ctx-b) [28–30], which is known to enter the 
cells by caveolin-mediated endocytosis [30,31]. We there-
fore used ﬂuorescent ctx-b as a control for inhibitors of 
caveolin-mediated endo cytosis. Furthermore, the inhibi-
tor dynasore was tested, which is known to interfere 
with both clathrin- and caveolin-mediated endo cytosis. 
Dynasore is a cell-permeable, reversible, noncompetitive 
inhibitor of dynamin, which is required for clathrin- and 
caveolin-mediated endocytosis [26].
Since the endocytotic pathways used by particles 
varies between cells and most chemical inhibitors of 
endocytosis might lack speciﬁcity or cause adverse side 
effects, we ﬁrst evaluated all inhibitors at different 
concentrations and incubation times in the presence 
of positive controls. The optimal conditions to inhibit 
caveolin- as well as clathrin-mediated endocytosis were 
then used to determine the intracellular number of Au 
NPs qualitatively as well as quantitatively by cutting-
edge microscopy methods such as TEM and LSM 
combined with digital image restoration and stereology. 
Materials & methods
Cell culture
Experiments were performed with the human alveolar 
epithelial type II cell line A549 obtained from American 
tissue Type Culture Collection. Cells were cultured in 
RPMI 1640 medium (GIBCO, Switzerland) and grown 
on six-well plates with cell-culture transwell inserts (BD 
Falcon, Germany), as described previously [15]. The cells 
were cultured for 7 days until they formed a conﬂuent, 
tight layer and cell growth reached a plateau [32]. The 
medium was changed twice a week and exposures were 
performed on day 7. 
NP synthesis & cell exposure
Hydrophobically capped Au NPs were synthesized as 
described previously [33]. The average NP size of the 
inorganic core was determined as 13.3 ± 0.5 nm by 
TEM (Figure 1A) and the concentration was measured 
by a UV/visible spectrometer (Agilent 8450) using 
an extinction coefﬁcient of 4.62 × 108 M-1cm-1 at the 
plasmon peak of 526 nm. For transfer into aqueous 
solution the NPs were coated with an amphiphilic 
polymer. The synthesis of the amphiphilic polymer, 
poly(isobutylene-alt-maleic anhydride) (M
w 
a6000 Da, 
Sigma #531278) with hydrophobic side chains, has 
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been described previously [34,35]. The ﬂuorescent dye 
ATTO 590 was furthermore incorporated into the 
polymer shell. The number of ﬂuorescent ATTO 590 
dye molecules per NP in the ﬁnal ATTO Au NP sample 
was estimated from the UV/visible absorption spectra 
(Figure 1B) by the respective absorption peaks of Au 
NPs and ATTO 590, as described previously [9,36]. 
A concentration of approximately 40 dye molecules 
per Au NP was measured. The ﬂuorescence emission 
spectra of the NPs and the free ATTO 590 dye are 
shown in Figure 1C. A more detailed protocol about the 
synthesis and characterization of the particles is reported 
in the Supplementary Material (see online at www.
futuremedicine.com/doi/suppl/10.2217/nnm.13.24).
Prior to exposure, NPs were diluted to a ﬁnal 
concentration of 1.5 nM (9 × 1011 NPs/ml, as 
determined by UV/visible absorption spectroscopy) in 
RPMI without serum and vortexed and sonicated three 
times for 5 min. A volume of 500 μl NP suspension was 
applied per six-well insert and the cells were exposed for 
1 h. All experiments were performed in triplicate with 
different cell passages. Cellular NP uptake, with and 
without inhibition of clathrin- or caveolin-mediated 
endocytosis, was analyzed by means of stereology after 
systematic random sampling on either LSM or TEM 
images. 
Endocytosis inhibition
Different endocytotic inhibitors were tested for their 
efﬁciency, speciﬁcity and cell toxicity.
Clathrin-mediated endocytosis
Inhibition of clathrin-mediated endocytosis was tested 
with chlorpromazine hydrochloride (C8138, Sigma-
Aldrich, Switzerland) used at ﬁnal concentrations of 50 
and 100 μM. 
Caveolin-mediated endocytosis
Inhibition of caveolin-mediated endocytosis was tested 
with ﬁnal concentrations of 25, 50 and 100 μM nystatin 
powder dissolved in tris (N6261, Sigma-Aldrich) and 
50 μM nystatin suspension (N1638, Sigma-Aldrich) in 
sterile phosphate-buffered saline (PBS), 1 μg/ml ﬁlipin III 
from streptomyces ﬁlipinensis (F4767, Sigma-Aldrich) 
and 10 mM mEcd (C4555, Sigma-Aldrich).
Both mechanisms
Inhibition of both mechanisms was carried out with 
40 and 80 μM dynasore monohydrate (D7693, 
Sigma-Aldrich).
Control experiments
Transferrin, coated with Alexa Fluor® 488 conjugate 
(T13342, Invitrogen, Switzerland), was used to test 
inhibition of clathrin-mediated endocytosis and ctx-b, 
labeled with Alexa Fluor 488 conjugate (C34775, 
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Figure 1. Characterization of gold nanoparticles. Polymer-coated Au 
NPs were characterized prior to use. A transmission electron microscopy 
image is shown in (A). Note that only the inorganic gold core but 
not the organic surfactant shell provides contrast. The average gold 
core size is 13.3 ± 0.5 nm. (B & C) Absorbance spectrum and emission 
spectrum, respectively, of Au NPs with polymer shell with and without 
incorporated ATTO 590 dye, and of polymer micelles with ATTO 590. 
NP: Nanoparticle.
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Invitrogen), was used to test inhibition of caveolin-
mediated endocytosis. Transferrin was dissolved in 
dH
2
O and 1% NaN
3
 and diluted in RPMI cell culture 
medium without serum to a ﬁnal concentration of 
120 μg/ml. Ctx-b was dissolved in 10 mM PBS (pH 
7.4) and 1% NaN
3
 and diluted to a ﬁnal concentration 
of 0.6 μg/ml PBS (pH 7.4) in RPMI prior to use.
Cell treatment
The cells were preincubated for 30 min with the 
inhibitors and further exposed to the endocytotic 
marker proteins either alone or in combination with 
the inhibitor (continuous inhibition). Exposures were 
carried out for 1 h. Inserts were cut into half and cells 
on one half were further processed and analyzed by 
means of LSM, as described below, and the other half 
for TEM.
Laser scanning microscopy
For LSM analysis, insert membranes with the cells were 
ﬁxed with 3% paraformaldehyde (Sigma-Aldrich) and 
stained with either rhodamine phalloidin (red signal 
emission) or Alexa Fluor 633 phalloidin (far red signal 
emission; both Invitrogen) as described previously 
[15]. Analysis was performed with an inverted Zeiss 
LSM 510 Meta (Axiovert 200M, Zeiss, Switzerland) 
equipped with Argon/2 488 nm, HeNe 543 nm and 
HeNe 633 nm lasers. Image stacks were acquired with 
a 63× objective, twofold digital zoom and step size of 
0.3 μm between z-stacks. Five different image stacks 
were randomly selected per insert membrane. In order 
to assure the randomness of the selected images and to 
give each area of the cell culture membrane an equal 
opportunity of being sampled, a random position 
outside of the cell culture membrane was determined, 
followed by a constant and deﬁned x/y step movement 
and image acquisition at each randomly selected 
position on the cell membrane. See elsewhere for further 
details on unbiased, systematic random sampling [37]. 
After acquisition, scans were deconvolved by Huygens 
essential software (SVI, The Netherlands) to reverse 
the point spread function and increase the resolution 
of the images [38]. One could regard the maximum 
likelihood estimation-based deconvolution used in 
Huygens as a nonlinear (near) energy-conserving ﬁlter.
The 3D information such as the volume, surface or 
intracellular structures of the cells of the LSM images 
was further analyzed with Imaris software (Bitplane, 
Zürich). Therefore, location of marker proteins or NPs 
could be conﬁrmed inside cells and intracellular NP 
events were counted manually in each test ﬁeld (3D 
image stack with x/y area of 1600 μm2 and height 
of cells). Intracellular particle events were counted 
according to the disector method [39]; a particle event 
was counted if present in a z-stack image, but missing 
in the consecutive one. Note that resolution of LSM 
is limited and therefore NP agglomerates might be 
detected as one single particle event. The average 
number of NP events per cell (NP
Event
) was obtained 
by dividing the average intracellular NP events (N) per 
test ﬁeld (A) with the mean cell number (C) per test 
ﬁelds (Equation 1). The average number of cells per test 
ﬁeld was manually counted as well. Therefore, the x/y 
image border was used as an unbiased counting frame, 
including cells cut by the upper x-axes and the right 
y-axes and excluding cells cut by the lower x-axes and 
the left y-axes.
/
/NP
C A
N A
Event=  (Equation 1)
Transmission electron microscopy
The other half of the insert membrane with exposed 
cells was processed for TEM as described previously 
[15]. From the embedded cells, ultrathin sections 
were cut parallel to the vertical axis of the cells, 
mounted on copper grids and stained with lead 
citrate and uranyl acetate. Imaging was done at a 
magniﬁcation of 22,000× with a Morgani TEM (FEI 
Co Philips Electron Optics, Zürich, Switzerland). NP 
quantiﬁcation was carried out by means of stereology 
as previously described [33]. Stereology is applied 
to estimate 3D structures, such as volume, surface, 
length or numbers from 2D images/sections. Here, the 
density of intracellular particles (N
V
) was evaluated 
ﬁrst and then multiplied with the average cell volume 
(V
C
) to obtain the average number of NPs per cell 
(NP
Cell
). Note that due to the better resolution of TEM 
compared with LSM individual NPs could be resolved 
and thus counted. 
From every experiment, three random ultrathin 
TEM sections were screened by systematic 
uniform random sampling for intracellular NPs 
at a 2200× magniﬁcation. NPs were counted only 
if they occurred within a deﬁned test ﬁeld area 
(1.76 × 2.94 μm = 5.19 μm2) placed randomly over 
the cell images. The intracellular localization of each 
NP was further recorded to estimate the average 
intracellular NP distribution. The intracellular particle 
density (N
V
) was obtained by dividing the number of 
intracellular NPs (N) in all test ﬁelds (n) to the total 
sampling volume (Equation 2). The total volume was 
estimated by multiplying the number of sampled test 
ﬁelds (n) with the test ﬁeld area (A) and the section 
thickness (d). The section thickness was half of the 
diameter of the smallest fold, which was measured 
with TEM [40].
/N N n x A xdv= ^ h (Equation 2)
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To estimate the mean cellular volume of the A549 
cells, V
C
, the vertical rotator [41] was used on semi-
thin sections, which were stained with toluidine blue. 
Visualization and analysis was performed with a 
conventional light microscope coupled to a newCAST 
system (CAST 2.0, Olympus, Ballerup, Denmark) at 
an objective lens magniﬁcation of 600×. If a nucleolus 
was observed in an A549 cell, the cell was sampled for 
the cell volume estimation on vertical uniform random 
section by the nucleator, which can be used to estimate 
the volume from a 2D vertical uniform random 
section. The mean cell volume, V
C
, was estimated for 
each experiment. The average number of NPs per cell, 
NP
Cell
, was further obtained by using Equation 3:
NP N xVCell V C=  (Equation 3)
Note that effects of uneven cellular shrinkage 
during processing of TEM and LSM samples were 
considered as irrelevant for comparison on intracellular 
particle number, since the cellular reference volume 
was established separately for TEM and LSM samples 
post-preparation to avoid any conﬂict of shrinkage 
between the two techniques. For further readings on 
the effect of tissue shrinkage and particle counts we 
refer the reader elsewhere [42].
Lactate dehydrogenase assay
In each experiment, 1 ml of the supernatant was 
sampled for the lactate dehydrogenase (LDH) assay 
to determine cytotoxicity [43]. Brieﬂy, Triton X (2% in 
RPMI, 30 min preincubation) was used for cell lysis 
and the positive control. The supernatant of untreated 
cell was used as the negative control. The LDH assay 
was performed with the Cytotoxicity Detection Kit 
(Roche Applied Science, Germany) according to the 
supplier’s manual. Each supernatant was measured in 
triplicates.
Statistics
To investigate the signiﬁcance (p < 0.05) of the LSM 
and TEM results, the Sigma Stat program for Windows 
(Version 3.10, Systat Software, Inc., Richmond, CA, 
USA) was used. With one-way analysis of variance, 
pairwise multiple comparison procedure (Student-
Newman-Keuls) was tested. Results are presented as 
mean (n = 3) ± standard error of the mean.
Results
A549 cells were grown for 7 days on a membrane 
insert as described [32]. Under these conditions, the 
cell number doubles and then levels off within 5 days 
in culture, which is important in order to provide the 
fully functional properties of epithelial cells [44]. 
Endocytotic inhibitors
Different inhibitors of clathrin- and caveolin-mediated 
endocytosis were tested for their speciﬁcity and cell 
toxicity. Fluorescently labeled transferrin, which 
was shown to enter the cells by clathrin-mediated 
endocytosis [45], and ﬂuorescently labeled ctx-b, 
which enters via caveolin-mediated endocytosis [46], 
were used to test efﬁciency and speciﬁcity of the 
inhibitors (Figure 2). Cell viability was analyzed either 
morphologically by LSM and TEM (Figure 3) or by the 
LDH assay. The results of all inhibition experiments 
are summarized in Table 1 and the results of the LDH 
assay are shown in Table 2.
Optimal inhibition of clathrin-mediated endocytosis, 
which was tested with ﬂuorescently labeled transferrin 
and analyzed by LSM, was achieved by 50 and 
100 μM chlorpromazine (Figure 2A). Chlorpromazine 
was shown to be very speciﬁc in inhibiting uptake of 
transferrin but not ctx-b (Figure 2E) and did not affect 
the cells, even when the concentration or incubation 
time was increased. 
Caveolin-mediated endocytosis was best inhibited 
by 10 mM mEcd (Figure 2D). However, although it is 
generally stated that mEcd inhibits both caveolin- as 
well as clathrin-mediated endocytosis [47], clathrin-
mediated endocytosis was observed when the cells 
were exposed to mEcd since only partially inhibited 
transferrin uptake was seen (Figure 2B). Furthermore, 
cells could only be exposed to mEcd for a limited 
time period (30 min preincubation) since the cell 
morphology and epithelial integrity were affected by 
prolonged exposure for 90 min. Exposure times were 
therefore limited to 30 min before addition of NPs. 
Caveolin-mediated endocytosis was only successfully 
inhibited by mEcd, since nystatin, neither as a powder 
dissolved in tris buffer nor in suspension directly 
received from the supplier, was capable of inhibiting 
cellular ctx-b uptake via caveolin-mediated endocytosis, 
even when the inhibitor concentration or incubation 
time was increased. Filipin, another potential inhibitor 
of caveolin-mediated endocytosis, did not inhibit the 
uptake of ctx-b, but the cell morphology and epithelial 
integrity was negatively affected (Figure 2F).
The inhibitor dynasore, which is known to interfere 
with both clathrin- as well as caveolin-mediated 
endocytosis via reversible and noncompetitive 
inhibition of dynamin, was not effective at 
an exposure time of 30 min even at increased 
concentrations (Figure 2C). However, at prolonged 
exposure times, the inhibitor led to a strong auto-
ﬂuorescent cell signal associated with a loss of cell 
viability.
In addition, morphological analysis of cells treated 
with and without endocytotic inhibitors was assessed 
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by LSM and TEM, revealing that the morphology as 
well as the actin cytoskeleton was not impaired in the 
presence of the inhibitors (Figure 3).
Cellular NP uptake
The cells were exposed to a ﬁnal concentration of 1.5 nM 
Au NPs for 1 h after preincubation with the opti mal 
endocytotic inhibitors (chlorpromazine, mEcd or 
none). Intracellular NPs were further visualized by 
either LSM or TEM and quantiﬁed by stereological 
approaches as described in the ‘Materials & methods’ 
section.
NP uptake evaluation by LSM
Visualization of intracellular NPs in A549 cells by 
LSM with or without inhibitors and their quantitative 
evaluation are shown in Figure 4. The NPs could 
be detected inside A549 cells as NP events (control 
without inhibitor; Figure 4A), whereby one NP event 
refers to one individual spot of ﬂuorescence, which 
likely corresponds to an NP-ﬁlled vesicle as previously 
shown for other ﬂuorescent NPs [48]. As shown in 
Figure 4B, chlorpromazine did not inhibit NP uptake 
and intracellular NP events were still detected. 
Almost no intracellular NPs were seen in the presence 
of mEcd and NPs were mostly attached to the outer 
cell membrane (Figure 4C). Next, we counted the 
intracellular NP events, resulting in 42.2 ± 13.4 NP 
events/cell for noninhibited cells (control), 60.8 ± 11.4 
for chlorpromazine-treated cells and 13.1 ± 3.8 for 
mEcd-treated cells (Figure 4D). Hence, cells treated 
with mEcd showed a 69% inhibition of NP uptake 
compared with untreated controls, whereas treatment 
with chlorpromazine surprisingly resulted in a 
43% increase in NP uptake. However, a signiﬁcant 
difference (p = 0.042) of intracellular NP events 
was measured between mEcd- and chlorpromazine-
treated cells, but not between treated and untreated 
control cells.
NP uptake evaluation by TEM
The evaluation of intracellular NP numbers by 
TEM resulted in the total number of NPs, since 
TEM, in comparison to LSM, allows the resolution 
and detection of single particles. Intracellular NPs 
as detected by TEM and the average cellular NP 
numbers are shown in Figure 5. In the TEM images 
(Figures 5A–C) we could conﬁrm that NPs were 
localized in vesicles of different sizes, which indicates 
endocytotic NP uptake. The number of NPs taken 
up per cells was 5365 ± 779 for noninhibited cells, 
10612 ± 1169 for chlorpromazine-treated cells and 
1992 ± 788 for mEcd-treated cells (Figure 5D). 
Hence a signiﬁcant difference (p < 0.05) in the 
numbers of intracellular NPs between control and 
chlorpromazine- or mEcd-treated cells was measured 
as well as between chlorpromazine- and mEcd-treated 
cells. The number of mean intracellular NPs was 
twice as high in the cells treated with chlorpromazine 
and a 63% decrease was seen in mEcd-treated cells 
compared with the positive control. Therefore, the 
10 μm 10 μm
10 μm
10 μm
10 μm
10 μm
Figure 2. Inhibitor speciﬁcity and efﬁciency of clathrin- and caveolin-
mediated endocytosis. (A–C) Clathrin-mediated endocytosis was tested 
with ﬂuorescent transferrin (green) uptake into the cells (red cytoskeleton) 
within 1 h of exposure time. (A) A 30-min preincubation with 100 μM 
chlorpromazine was shown to inhibit clathrin-mediated endocytosis, 
whereas a 30-min preincubation with (B) 10 mM methyl-E-cyclodextrin or 
(C) 80 μM dynasore did not. Caveolin-mediated endocytosis was tested with 
ﬂuorescent choleratoxin subunit b (green) uptake within 1 h of exposure 
time as shown in ﬁgures (D–F). (D) A 30-min preincubation with 10 mM 
methyl-E-cyclodextrin successfully inhibited choleratoxin subunit b uptake, 
but preincubation with (E) 100 μM chlorpromazine or (F) 100 μM ﬁlipin did 
not result in inhibition of caveolin-mediated endocytosis.
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trends observed by TEM and LSM were similar, but 
only by TEM is it possible to evaluate the total NP 
number. The results suggest that a detected ﬂuorescent 
signal covers on average a cluster of 150 NPs.
The intracellular localization of the NPs was further 
evaluated and it was shown that 95% or more of the 
NPs were located in intracellular vesicles (Figure 6). 
The remaining intracellular NPs were detected free 
in the cytosol and no particles were found in any 
other cellular organelles such as the mitochondria, 
nucleus or endoplasmic reticulum. These results show 
that endocytosis is the foremost method of cellular 
NP internalization. The inhibition of different 
endocytotic pathways did not result in a difference 
in cellular NP localization (% NPs in vesicle: control 
94.9 ± 3.1, chlorpromazine inhibition 99.8 ± 0.1, 
mEcd inhibition 98.6 ± 1.0).
Discussion
The great potential of nanosized particles such as 
Au NPs for diagnostic and therapeutic applications 
requires a thorough understanding on how these NPs 
interact with cells and how they are taken up, and 
their subsequent detection and localization within 
cells is of central importance [49]. Once intracellular 
NPs are identiﬁed, their distribution in different 
cellular compartments, such as endosomes, lysosomes, 
mitochondria, the nucleus or cytosol, may also 
provide some indications as to a potential diagnostic 
or drug delivery system. By using well-deﬁned and 
characterized ﬂuorescently labeled polymer-coated Au 
NPs, two different quantitative microscopy methods 
could be directly compared: the ﬂuorophore was 
analyzed by LSM and the electron dense Au core by 
TEM. These two methods were then applied to reveal 
the uptake mechanism using lung cells in vitro with 
inhibitors for various endocytotic uptake pathways.
Efﬁcient inhibition of clathrin- & caveolin-
mediated endocytosis
Various studies have been performed using chemical 
inhibitors of endocytosis to analyze uptake 
mechanisms of NPs into cells [12,50,51]. However, 
efﬁciency of inhibitors might vary within cell types 
and depends on exposure concentration and time. 
It has, for instance, been shown that the same NP 
type can explore different uptake mechanisms to 
enter different cell types [50]. In addition, inhibitors 
can induce cytotoxicity at higher concentrations. We 
therefore carefully analyzed commonly used inhibitors 
of endocytotic pathways. In A549 cells, we found that 
efﬁcient inhibition of clathrin-mediated endocytosis 
was only achieved with 100 μM chlorpromazine and 
caveolin-mediated endocytosis with 10 mM mEcd 
(30 min preincubation, Table 1). Although mEcd 
partially inhibited clathrin-mediated transferrin 
uptake, as shown previously [47], this inhibitor was 
most speciﬁc in the inhibition of caveolin-mediated 
ctx-b uptake compared with the other inhibitors 
tested (Table 1). Cell viability was not affected by 
these two inhibitors at the used incubation times and 
concentrations. The lowest effective concentration 
of inhibitors was always chosen for the exposures 
to reduce possible cell damage. The other tested 
inhibitors were either less speciﬁc or damaged the cells. 
If not suitable for further exposure with NPs, some 
5 μm 10 μm
10 μm
10 μm
5 μm
5 μm
Figure 3. Morphological analysis of cells treated with and without 
endocytotic inhibitors. Cellular morphology of untreated control 
cells and cells exposed to endocytotic inhibitors at optimal inhibition 
conditions were compared by (A C & E) transmission electron microscopy 
and (B, D & F) laser scanning microscopy. Control cells without inhibitor 
treatment are shown in (A & B), cells treated with 100 μM chlorpromazine 
for 30 min in (C & D) and cells treated with 10 mM methyl-E-cyclodextrin 
for 30 min in (E & F). Cells of both inhibitor conditions appeared healthy 
and viable, comparable to control cells. Red stain: cytoskeleton. 
m: Cell culture membrane; N: Nuclei.
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inhibitors and marker proteins were not checked in the 
pre-experiments (Table 1). Dynasore was previously 
described to inhibit caveolin-mediated uptake of ctx-b 
in human osteosarcoma cell lines at a concentration 
of 80 μM following preincubation for 30 or 60 min 
[52]. In our study, dynasore only showed inhibition 
when used at higher concentrations and the inhibition 
was prominent for transferrin uptake as well as for 
ctx-b uptake [26,53]. Nevertheless, dynasore was not 
optimal because of adverse effects such as impairment 
of cell viability. The inhibitor ﬁlipin was shown 
to inhibit ctx-b uptake by 58% in CaCo-2 human 
intestinal epithelial cells [28], as well as in A549 cells 
at a concentration of 1 μg/ml with a preincubation 
time of 30 min [27]. A reduction of caveolin-mediated 
transcellular transport of albumin was also shown by 
ﬁlipin [54]. However, in the current study, no efﬁcient 
inhibition of caveolin-mediated endocytosis could be 
achieved by this inhibitor, although similar conditions 
were used. It can be assumed that the instability of 
the inhibitor [55] might be responsible for the lack of 
inhibition over time. Since no inhibition in the uptake 
of ctx-b was achieved but cellular damage occurred, 
ﬁlipin was not considered as an optimal inhibitor for 
our study. Nystatin, in tris or in suspension, did not 
show any inhibition, even at high concentrations. 
It has been suggested that this inhibitor is used in 
combination with the hormone progesterone for 
increased efﬁciency [56].
Cellular NP uptake
It was shown that more than 95% of the intracellular 
Au NPs imaged by TEM were detected within 
Table 1. Analysis of speciﬁcity and efﬁciency of the different endocytotic inhibitors.
Inhibition of clathrin-mediated endocytosis
Inhibitor exposure Inhibition-positive 
control (transferrin)
Inhibition-negative 
control (ctx-b)
Cell viability
Chlorpromazine 100 μM 30 min Inhibition No inhibition Good
Chlorpromazine 100 μM 90 min Inhibition No inhibition Good
Inhibition of caveolin-mediated endocytosis
Inhibitor exposure Inhibition-positive 
control (ctx-b)
Inhibition-negative 
control (transferrin)
Cell viability
Nystatin 100 μM 30 min No inhibition Not tested Good
Nystatin 100 μM 90 min No inhibition Not tested Good
Filipin 100 μM 30 min No inhibition Not tested Impaired
Filipin 100 μM 90 min No inhibition Not tested Impaired
mEcd 10 mM 30 min Inhibition Slight inhibition Good
mEcd 10 mM 90 min Inhibition Inhibition Impaired
Inhibition of dynamin-dependent endocytosis 
Inhibitor exposure Inhibition-positive 
control (transferrin)
Inhibition-positive 
control (ctx-b)
Cell viability
Dynasore 40 μM 30 min No inhibition No inhibition Good
Dynasore 40 μM 90 min No inhibition Not tested Good
Dynasore 80 μM 30 min No inhibition Not tested Impaired
Dynasore 80 μM 90 min Inhibition Slight inhibition Impaired
$IFFERENT COMMON ENDOCYTOTIC INHIBITORS WERE TESTED FOR SPECIlCITY EFlCIENCY AND CELL IMPAIRMENT AT VARIOUS CONCENTRATIONS AND EXPOSURE 
TIMES &LUORESCENTLY LABELED PROTEINS SUCH AS TRANSFERRIN AND CTXB WERE USED TO TEST THE GRADE OF INHIBITION 4RANSFERRIN WAS USED AS A 
MARKER FOR CLATHRINMEDIATED ENDOCYTOSIS AND CTXB FOR CAVEOLINMEDIATED ENDOCYTOSIS )MPAIRED CELLS SHOWED SIGNS OF MEMBRANE DISRUPTION 
LOSS OF INTEGRITY AND LOSS VIABILITY AS DETECTED BY A STRONG SIGNAL OF  AUTOmUORESCENCE 
CTXB #HOLERATOXIN SUBUNIT B MECD -ETHYLECYCLODEXTRIN
Table 2. Cell viability of particle- and inhibitor-exposed cells.
Cell OD
Untreated cells (negative control) 1.33 ± 0.25
Lysed cells (positive control) 1.61 ± 0.25
Cells + 1.5 nM NP 1.32 ± 0.17
Cells + 1.5 nM NP + 100 μM chlorpromazine 1.21 ± 0.19
Cells + 1.5 nM NP + 10 mM mEcd 1.07 ± 0.11
#ELL VIABILITY WAS MEASURED WITH THE LACTATE DEHYDROGENASE ASSAY IN CONTROL CELLS AND CELLS 
TREATED WITH INHIBITORS OF ENDOCYTOSIS FOR  MIN AND EXPOSED TO .0S FOR  H 2ESULTS ARE 
PRESENTED AS THE MEAN /$ OF AN N   ¢ STANDARD ERROR OF THE MEAN
mECD -ETHYLECYCLODEXTRIN .0 .ANOPARTICLE /$ /PTICAL DENSITY 
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vesicles. We therefore conclude that these speciﬁc NPs 
enter the cells via endocytosis. This is in accordance 
with another study where differently coated Au NPs 
were mainly found in intracellular vesicles and only 
rarely in the cytosol. The Au NPs were not found 
in other intracellular compartments, such as the 
Golgi apparatus, endoplasmatic reticulum, nucleus 
or mitochondria [33]. However, coating of NPs 
with polyethylene glycol can signiﬁcantly increase 
the particle number in the cytosol compared with 
uncoated particles [33]. In order to avoid any protein 
effects we used serum-free medium for the particle 
exposure.
The visualization of NP uptake by LSM and 
TEM and quantiﬁcation suggest partial uptake of 
the polymer-coated Au NPs by caveolin-mediated 
endocytosis. The uptake of Au NPs via caveolin-
mediated endocytosis has already been observed in 
previous studies [23,51,57,58]. These studies, however, 
used different models and differently modiﬁed and 
sized particles. For example, Hao and colleagues found 
a mEcd-mediated uptake inhibition of 10 nm cystein-
cy5-coated Au NPs in HeLa cells [51]. The results 
of an in vivo study by Naota and colleagues showed 
localization of 20-nm plain, colloidal Au NPs in 
caveolin-1-positive stained vesicles in air–blood barrier 
cells in mice [58]. In a previous study with A549 cells 
and 15-nm sized plain and polyethylene glycol-coated 
Au NPs we found a mEcd-mediated inhibition after 
1 h of 86 and 97%, respectively [33]. Particle-speciﬁc 
coatings therefore seem to determine cellular uptake 
mechanisms to a great extent. In the current study with 
polymer-coated Au NPs, only partial inhibition (63% 
inhibition) was achieved by mEcd. This suggests that 
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Figure 4. Particle uptake analyzed by means of laser scanning microscopy. (A–C) Representative ﬂuorescent 
confocal micrographs show cellular NP uptake (NP: yellow; cytoskeleton: red). Intracellular NP events (white arrow) 
can be detected (A) within the cells of untreated cells and (B) cells incubated with chlorpromazine. As shown in (C), 
cellular uptake was reduced after mEcd treatment. Quantitative evaluation of cellular NP uptake is shown in (D), 
revealing a signiﬁcant (*p > 0.05) decrease in NP uptake of mEcd- compared with chlorpromazine-treated cells. 
mEcd: Methyl-E-cyclodextrin; NP: Nanoparticle.
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another prevalent mechanism could be involved such 
as macropinocytosis, clathrin-mediated endocytosis, 
or clathrin- and caveolin-independent endoytosis, as 
described previously [33]. However, we can exclude 
any NP uptake via clathrin-mediated endocytosis, 
since inhibition of this pathway did not decrease 
cellular NP uptake. On the contrary, chlorpromazine 
even induced a twofold increase of intracellular NPs 
compared with the control. This was observed by 
visualization and quantiﬁcation methods via LSM 
and TEM. This increase was not expected because 
chlorpromazine was shown to efﬁciently inhibit the 
marker protein transferrin in the pre-experiments. In 
this case, we can further exclude any cellular NP entry 
due to disruption of the apical plasma membrane, since 
neither the LDH assay nor TEM images gave evidence 
of membrane distortion. Previous studies have shown 
that an inhibition of clathrin-mediated endocytocis 
can result in an increase in cellular macropinocytosis 
[59,60]. In accordance with our previous results that 
demonstrate that plain Au NPs stabilized with citrate 
enter A549 cells via macropinocytosis, it is very likely 
that the increase in intracellular NP number after 
inhibition of clathrin-mediated endocytosis results 
from enhanced macropinocytotic uptake. However, 
in other studies, NPs have often been described to be 
internalized via clathrin-mediated endocytosis [61,62] 
and chlorpromazine was shown to inhibit the uptake 
of ﬂuorescein isothiocyanate–chitosan NPs in A549 
cells [61]. The variety of different parameters, such 
as size, surface charge and coating or cell type, used 
in the different studies likely explain the different 
observations in the literature. This indicates that an 
adjusted experimental design is required, speciﬁcally 
when using different cell types, to learn more about 
the cellular mechanisms of NP interaction and uptake.
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Figure 5. Nanoparticle uptake analyzed by means of transmission electron microscopy. (A–C) Intracellular NPs are shown in 
transmission electron micrographs. NPs (black arrow) can be detected within the (A) untreated cells and (B) cells incubated with 
chlorpromazine, as well as to a lesser extent in (C) mEcd-treated cells. NPs were all detected within some vesicular structures, but 
neither free in the cytosol nor within the nucleus or organelles such as mitochondria. A quantitative evaluation of the intracellular NP 
number is shown in (D), revealing a signiﬁcant (*p > 0.05) increase of intracellular NPs in chlorpromazine-treated cells and a decrease 
in mEcd-treated cells compared with the control. 
M: Mitochondria; mEcd: Methyl-E-cyclodextrin; N: Nuclei; NP: Nanoparticle.
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Stereological NP quantiﬁcation via TEM & LSM 
Both LSM and TEM analysis experiments were 
evaluated manually by means of stereology and a 
similar trend in the uptake ratio within experiments 
could be observed. An approximation of the 
incorporated amount of NPs per cell was determined 
by LSM combined with digital image restoration 
as previously described [9]. As indicated earlier, the 
resolution limit of light microscopy prevented us from 
distinguishing between single NPs observed with 
TEM and small NP agglomerates (events) observed 
with LSM. It is also well known that NPs inside cells 
are clustered in small vesicular structures and each 
vesicle can contain multiple NPs [48,63]. Therefore we 
counted ‘NP events’ in LSM, whereby one NP event 
likely corresponds to an individual vesicular structure 
that contains NPs. In this way we could quantify 
relative differences in the amount of incorporated 
NPs per cell under various uptake inhibitory 
conditions. Comparing the two approaches, we 
found approximately 150-times more NPs/cell in 
TEM than NP events/cell in LSM images. Note that 
TEM allows the individual resolution of intracellular 
NPs, whereas LSM does not. It has to be considered 
that NP characteristics, such as ﬂuorescent intensity 
and wavelength, size, surface charge and tendency to 
form agglomerates, strongly affect particle resolution 
by LSM. The magnitude of the observed difference 
between the two techniques is therefore particle 
dependent and needs to be established individually 
for different NP types. It further has to be noted that 
more advanced LSM techniques in the category of 
super resolution laser microscopy such as stimulated 
emission depletion microscopy have recently become 
available. Thus, LSM resolution can be improved and 
LSM may become more appropriate for intracellular 
NP imaging [64].
Despite the limitation of single NP resolution by 
conventional LSM, the same trend in relative increase 
or decrease after endocytotic inhibition was observed 
with both techniques. There was a smaller divergence, 
however, between the mean values of the positive 
control and inhibition with chlorpromazine in the 
LSM results (30%) compared with the TEM results 
(50%). Therefore, the trend became more apparent 
in the results evaluated by TEM. Nevertheless, 
both methods showed an inhibition of NP uptake 
after mEcd treatment. Comparing the mean values 
of the positive control and inhibition with mEcd, 
the LSM results revealed a 96% distinction and 
TEM a 63% distinction. With the LSM approach, 
between 10 and 60 NP events were counted on 
average in control conditions in comparison to the 
individual NPs counted with the TEM method 
(mean: 5365 NPs). When visualizing the samples 
with TEM, it is also possible to detect single NPs and 
differentiate them from agglomerates, which, due to 
the optical resolution limit, is not possible with LSM. 
Another problem with LSM quantiﬁcation is that 
ﬂuorescent dyes might uncouple and separate from 
the gold cores. While strict puriﬁcation made sure 
that only intact NPs were added to the cells, inside 
cells the polymer shell with the ﬂuorophores may 
partially be removed from the NPs by intracellular 
degradation. At present, little is known about the 
integrity of NPs after incorporation by cells. When 
detecting the ﬂuorescent signals, it is unfortunately 
not possible to determine whether or not the dyes 
are attached to the NPs. These problems also persist 
when the intracellular particle number is estimated 
by mean ﬂuorescent intensity signal. Measuring 
cellular particle uptake via ﬂuorescent intensity, such 
as by ﬂow cytometry, is an easy and straightforward 
approach that has been used previously [65]. However, 
pitfalls such as intracellular signal quenching or 
uncoupling of ﬂuorescent dyes remain and become 
more critical when particle types of different size, 
charge or ﬂuorescent signals are compared with each 
other. In comparison, electron microscopy-based 
evaluations are certainly more labor intensive, but 
provide better resolution and allow the NPs to be 
assigned to the different intracellular compartments 
and quantify their relative intracellular localization 
[66]. Stereology is therefore the method of choice 
for quantifying cellular particle numbers in 3D 
from 2D microscopic images. Besides the approach 
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Figure 6. Intracellular nanoparticle distribution. The intracellular 
NP localization was acquired by random sampling and counting 
approximately 500–1000 NPs per sample (n = 3 for each experimental 
condition). The NPs were located in vesicles (95% or more) and no 
signiﬁcant difference was found in intracellular localization after 
inhibition with chlorpromazine and mEcd. 
mEcd: Methyl-E-cyclodextrin; NP: Nanoparticle.
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described in this study and our previous study [33], 
another stereological design for quantifying cellular 
NP number by TEM has recently been proposed 
by Elsaesser and colleagues [37]. This approach uses 
the fractionator principle [67] and correlates the total 
amount of intracellular particles per sample with the 
total cell number per sample. The approach is easy to 
follow and well designed for convex cells in suspension. 
In the current study, however, we were using an 
adherent, alveolar epithelial cell line that was grown 
on an insert cell culture membrane. The application 
of the design presented by Elseasser and colleagues 
would therefore require an enzymatic digestion of 
the cells to detach them from the membrane. For 
this reason we preferred to use an approach that can 
be applied to any cell type and form and therefore 
allows quantiﬁcation of intracellular NPs in an intact 
cellular monolayer. For further information on the 
differences between the two approaches we refer 
the reader elsewhere [68,69]. In comparison to our 
study, Shapero et al. analyzed the time-dependent 
uptake of particles quantiﬁed by ﬂow cytometry and 
qualitatively analyzed by TEM and LSM microscopy 
[65]. Shah et al. used confocal Raman microscopy with 
a lateral resolution of 250 μm to quantify cellular 
particle uptake in correlation with ﬂuorescence 
intensity [70]. However, this method cannot provide 
any spatial information about the NPs in a speciﬁc 
intracellular compartment. Due to the limited 
resolution of confocal Raman microscopy, atomic 
emission spectroscopy was applied to get an estimate 
of the signal-to-particle ratio. This is certainly valid 
information and in future studies the application 
of inductively coupled plasma-mass spectroscopy 
as a further internal control in combination with 
the stereological approach should be considered. 
However, compared with all these studies, this 
study is, to the best of our knowledge, the ﬁrst to 
actually compare LSM with TEM resolution using a 
stereology-based approach and the same NPs for both 
microscopy methods.
Conclusion
In this study, two cutting-edge visualization and 
quantiﬁcation methods (LSM and TEM) were used 
to analyze the endocytotic uptake mechanisms for 
polymer-coated Au NPs (hydrodynamic diameter: 
21 nm) in A549 cells. Due to the ﬂuorophore and the 
electron-dense properties of the NPs we were able to 
use the same cultures incubated with the particles and 
directly compare them. Although many inhibitors 
are described in the literature for the various uptake 
pathways, efﬁcient inhibition was only achieved by 
100 μM chlorpromazine for clathrin-mediated and 
10 mM mEcd for caveolin-mediated endocytosis. 
Both inhibitors did not affect cell viability at the 
concentrations and incubation times used. Although 
we found in the literature many drugs that can be 
used to inhibit speciﬁc uptake pathways, only two 
out of the ﬁve inhibitors that we tested were effective 
and not cytotoxic. It is therefore indispensable to test 
for each cell type and each drug concentration the 
effectiveness of the inhibition by positive markers.
Furthermore, both visualization techniques 
revealed an inhibition of Au NP uptake with mEcd 
and thus revealed that caveolin-mediated endocytosis 
was the main uptake mechanism for the type of NP 
used in this study. In addition, we demonstrated that 
when using LSM only NP events and not the total 
numbers of NPs can be estimated. Furthermore, TEM 
analysis demonstrated that the estimated average Au 
NP number was in the range of several thousand per 
cell, and that more than 95% of the NPs were located 
in intracellular vesicles in the control as well as in 
drug-treated cells.
We have shown that the interactions of NPs with 
cells and quantiﬁcation of NP uptake by cells can 
only be investigated under controlled experimental 
conditions and using cutting-edge microscopy 
techniques combined with stereological analysis.
Future perspective
The potential biomedical application of any NP 
requires a precise knowledge about the uptake 
mechanisms into any cell and the subsequent 
intracellular particle distribution. Until recently, 
most of the nanoresearch has been dedicated to 
providing a detailed description of the synthesis and 
characterization of NPs and their possible cellular 
reactions; however, in most of the experiments the 
characterization of the biological part is completely 
missing. Our results have clearly shown that biology 
should not be neglected and that, in our experience, 
inhibitors for endocytotic uptake pathways need 
to be tested and optimized. In addition, different 
methods should be used for the same end points and 
here we combined two stereological approaches based 
on light and electron microscopy. The limitations 
of each system needs, however, to be considered for 
the interpretation of the results. Unbiased stereology 
for quantitative image analysis will therefore be an 
important tool, since qualitative or semiquantitative 
investigations can lead to misinterpretation, especially 
in the ﬁeld of NP–cell interactions. By understanding 
the underlying mechanism of the NP–cell interface 
we will have the possibility to design and optimize 
new nanotechnology approaches from basic research 
concepts to medical applications.
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